Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments:
0:00 Introduction
1:12 Journey from Electrical Engineering to Neuroscience
6:45 Initial Interest in Neuroscience
8:16 What is connectomics?
11:45 Parallels Between Microchip Design and Neuroscience
14:22 Probabilistic Reconstruction in Connectomics
19:46 Neurons Behaving Like Brain Regions In C. Elegans
22:17 Incorporating Biological Knowledge into Reconstruction Models and Techniques
25:47 Humans vs ML: Neuron Image Classification
28:05 Future of Connectomics
31:20 Expansion Microscopy
33:19 Genetic Barcoding
34:25 Synchrotrons and X-Rays
34:56 Combining Techniques
35:52 Connectomics: From Flies to Larvae Zebrafish - Optical Microscopy
37:19 Bee Neuroscience, Behavior, and Connectomics
40:03 Mouse Connectomics: Eventually Expansion and Exploration of More Complex Animal Brains
42:39 Any Possibility to Understand the Human Brain at this Level of Detail?
45:07 Tips for Breaking into Connectomics and Neuroscience
50:50 Why are gap junctions hard to see?
53:48 Connectomics Applied to Neuromorphic Computing
55:07 Alcoholic Fruit Flies: Connectomics Applied to Human Medicine
58:03 Conclusion and Contact Info
Dr. Scheffer’s email: LouScheffer@gmail.com
Recorded: 3/20/2024
Host: Robert Murcko
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments:
0:00 Introduction
4:36 Initial Interest in Neurotechnology
7:34 Exploring Diverse Fields of Interest: Neuromorphic Computing, Brain-Machine Interface, Heliostat Fields, Military Applications
10:51 MEMS
14:52 Bio-compatiblity and Bio-mimetic Systems in Neurotech
18:12 Neuromorphic Computing in Brain-Computer Interfaces
22:14 Integrating Device Engineering with Computing in Post-Doc
24:19 Challenges in Data Storage and Processing
27:19 MEMS Experience Transferring to Semi-Conductor Fabrication
28:38 Neuromorphic Computing Strategy for Neural Implants
30:41 Water-based Resistive Switches for Neuromorphic Connections
34:03 Challenges of Applying New Thought Process to Designing Architectures
36:51 Back to Neural Interfaces: Transitioning from Academia to Industry
39:32 Working in Industry: Translation, Engineering vs Business
41:59 What Expertise Does Neurotechnology Need More Of?
44:32 Brain Modeling: Companies vs Research Labs
45:56 Getting Involved in Neurotech - Advice for Students: Ask Questions, Don’t Rely on Jargon
49:21 Future of Neurotech: Next 20 Years
51:27 Book Recommendation: Outlive by Peter Attia
52:25 Book Recommendation: Thinking Fast and Slow by Daniel Kahneman, Build by Tony Fadell, CEO Excellence by Dewar et al.
53:45 Conclusion and Contact Info
Dr. Akshay Ananthakrishnan’s LinkedIn: https://www.linkedin.com/in/akshayy-91/
Recorded: 5/9/2024
Hosts: Robert Murcko & Yuqing Wang
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments:
0:00 Introduction
3:02 Founding Story: Connectome Health
6:15 Inspiration for Company Name: Connectome Health
8:12 fNIRS Overview and Connectome’s Modality Agnostic Strategy
10:23 Hardware
11:26 Key Brain Metrics
13:16 Goal to Move into NeuroDiagnostics
13:59 Scientific Validity and Research Behind Connectome’s Metrics
15:27 Strategy to Eventually Enter Clinical Space
18:07 Connectome User Experience
25:44 Current State of Connectome Health: Pre-Launch, Fundraising
27:02 Long-Term Vision for Connectome Health
29:47 Advice for Students or Young Professionals Interested in Neurotech
30:56 The Future of Neurotechnology
33:41 Book/Media Recommendations: Huberman Lab, Being You (by Anil Seth), The Spike (by Mark Humphries), The Old Man and The Sea (by Ernest Hemingway)
35:40 Conclusion
Connectome Health: https://www.connectome.health/
Recorded: 4/17/2025
Host: Robert Murcko
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments:
0:00 Introduction
3:17 Initial Interest in Neuroscience
4:50 Origin Story of Reach Neuro
6:16 Reach Neuro’s Avantis Platform
11:12 Reach Neuro Competitors
14:40 Navigating FDA Regulations and Breakthrough Device Designation
19:02 Research Tools and Product Development Feedback Loops
20:46 What is Next for Reach Neuro?
22:49 Algorithms and Spinal Anatomy
24:51 Breaking into Neurotech: Advice for Aspiring Professionals
26:28 The Jump from Academia to a Startup in Neurotech
28:14 The Future of Neurotechnology
30:56 Conclusion and Contact Information
Recorded: 2/7/2024
Host: Robert Murcko
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments:
0:00 Introduction
3:23 Initial Interest in Neuroscience/Neurotechnology
5:10 Neurovalens: Background, Timeline, Origins
7:52 Clinical Trials: Insomnia, Anxiety, Obesity, PTSD, Diabetes
8:40 Neurostimulation: Type and Target
10:40 Exploring Various Treatment Types with Neurovalens
17:29 Patient Experience
20:40 Target Nerves and Brain Regions
22:56 Competitors and Differentiators
25:32 What is next for Neurovalens?
27:34 Commercialization
29:55 Patient Education
30:39 Refund if it doesn’t work
31:53 Wellness Device - Big Learnings and Initial Sales
33:40 Early Adopters and Crowdfunding: Indiegogo
35:44 Real World Data and FDA Guidance
37:17 FDA Involvement in Wellness Space
40:23 FDA Confusion Launching Wellness Sleep Product
43:01 Advice for Breaking into Neurotech: Students/Young Professionals
45:14 The Future of Neurotech (20 years)
47:47 Community/Collaboration/Contact
Recorded: 2/8/2024
Host: Robert Murcko
Neurovalens: https://neurovalens.com/
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments
0:00 Introduction
2:22 Initial Interest in Neuroscience/Neurotech
4:17 Background and Origins of Synaptrix
6:15 Development of Neuralis Product
7:10 Benefits of Building a Product “In-House”
8:54 In-House Lab Build Out
10:41 Moving Quickly Through Regulatory Stages
11:40 Guardrails Helping Keep Safety and Efficacy Paramount
13:34 Saffron 1 Model
17:01 Saffron 2 and 3 in Development
18:08 Generalizability (“Fluid Matrices that Respond in Real Time to Brain Data)
18:50 Why More Bandwidth is Useful
19:50 Future Path: A Non-Invasive Option for Non-Binary Motor Imagery
20:47 Clinical Study: Empower Study
23:41 Raising Venture Capital
24:48 VC vs Grants: Difference in Requirements
26:26 What is next for Synaptrix?
28:09 Form Factor
29:33 Breaking Into Neurotech
32:26 Breaking Into Neurotech From An Alternate Route
33:54 Predictions for Neurotechnology
36:37 Conclusion and Contact Information
Aryan Govil LinkedIn: https://www.linkedin.com/in/aryangovil/
Synaptrix Labs: https://www.synaptrix-labs.com/
Host: Robert Murcko
Recorded: January 18, 2024
Please note this episode was recorded when Dr. Krinke was still in his former position as of CEO at Newronika.
Key Moments
0:00 Introduction
5:01 Initial Interest in Neuroscience
7:04 Newronika: Background and Origins
9:11 Closed Loop Deep Brain Stimulation Methodology
12:39 Does Closed Loop DBS Pose Additional Risks?
15:20 Newronika WebBioBank
17:07 Data Science/AI: Detecting Waking Up & Freezing of Gait Directly Through the Brain
20:47 What’s Next for Newronika
22:39 Clinical Trial Framework
23:41 Advice: How to Get Involved in Neurotech
27:09 The Future of Neurotech
31:54 Conclusion: Investing, Collaborators, Europe Launch
Host: Robert Murcko
Recorded: January 25, 2024
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Newronika: https://newronika.com/
Lothar Krinke LinkedIn: https://www.linkedin.com/in/lothar-krinke-81955817/
Key Moments
0:00 Introduction
6:25 Master of Surgery Degree
7:57 Initial Interest in Neuroscience/Neurotechnology
9:37 Bionic Vision Technologies
13:56 BVT Clinical Trials
16:27 BVT Compared to Other Visual Prosthetics and Solutions
21:12 Patient Experiences: Regaining Vision and Confidence
23:11 Ties Between Cochlear and BVT
26:23 What’s Next for BVT?
28:37 Neurotech CEO: Day-to-Day Picture
30:16 How to Get Involved in Neurotech
32:57 The Future of Neurotech
34:07 Conclusion and Contact Info
Host: Robert Murcko
Recorded: January 16, 2024
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Key Moments
0:00 Lee Sidebottom Introduction: Director of Concept Applications at NeuroTracker
5:29 Initial Interest in Neuroscience
12:14 Brain Imaging Technologies Utilized: Currently qEEG. fMRI in Future?
14:55 Early Technology Transfer and Living with CEO
19:52 What is NeuroTracker Working On? Closed-Loop EEG, AR/VR
23:43 NeuroTuner - Exclusive Details - Never Publicly Mentioned Before
32:37 Study with US Air Force: Pilot Training Next
34:28 Learning Curves of Various Populations
37:05 Study with Stock Market Traders
37:53 Longitudinal Study NFL/NHL Combines
39:05 Study with Special Forces
40:10 Studies with French Rugby Team: Blood-Based Biomarkers & Fatigue
42:31 Studies in E-Sports
44:50 Is NeuroTracker Customized for Different Uses and Domains?
50:32 Predictions for Neurotechnology Over Next 20 Years
55:18 Conclusion and Contact Info
Host: Robert Murcko
Recorded: January 12, 2024
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Neurotracker: https://www.neurotrackerx.com/
Lee Sidebottom LinkedIn: https://www.linkedin.com/in/lee-neurotracker/
Dr. Faubert’s Google Scholar: https://scholar.google.ca/citations?user=PDodkWEAAAAJ&hl=fr
3D-Multiple Object Tracking training task improves passing decision-making accuracy in soccer players (Paper): https://www.sciencedirect.com/science/article/pii/S1469029215000631
Critical Review of NeuroTracker (Paper): https://pubmed.ncbi.nlm.nih.gov/33821464/
Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe
Nao Yukawa is a founder of the startup DeMind. Their main product is an app called Lifestack which helps you “Schedule Your Day with Energy in Mind” by using physiological data from your wearables and contextual data from your calendar and other sources. Nao and his cofounders at DeMind have had an exciting journey so far - they pivoted away from their original idea, are finding some solid traction with this one, raised an investment round to help super charge their growth, and even pitched to legendary angel investor Jason Calacanis. Regarding whats next: in the future, Lifestack may support neural signal data as one of the app’s inputs. They are also looking to further expand the contextual data they utilize for a more seamless and intuitive experience. Those interested in the neurotech and wearable startup scene should keep an eye on Nao and his team. Recorded: July 25, 2024. Host: Robert Murcko
Key Moments
0:00 Introduction
2:41 Initial Interest in Wearables and Neurotechnology
4:32 Pitching to Jason Calacanis and Founder University
7:02 Juggling Attending Two Universities at Once
8:42 Founding Story Behind DeMind
10:37 Previous Projects and Pivot to Lifestack
13:09 Future Directions: Incorporating Neural Signals into Lifestack
15:33 Lifestack Competitors
16:08 Integrating with Existing Calendar Apps
17:35 Long-Term Goals: Combining Physiological and Contextual Data
19:37 Advice for Getting Involved with Wearables and Neurotech
21:05 Predictions: The Future of Neurotechnology and Wearables
22:17 Book Recommendation: “The Mom Test” and Neuroscience Textbooks
24:42 Where to Find the Lifestack App
25:28 Conclusion and Contact Information
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Lifestack App: https://lifestack.ai/download
Lifestack on Product Hunt: https://www.producthunt.com/products/lifestack
Nao Yukawa LinkedIn: https://www.linkedin.com/in/naoyukawa/
Nao Yukawa Twitter: https://x.com/nyneurotech
Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe
Dr. Iris Brunner (PT, PhD) is an Associate Professor and Researcher at the University of Aarhus’ Hammel Neurocenter in Denmark. She works in the domain of physiotherapy and neuro-rehabilitation. She is both a researcher and a clinician. Her areas of interest include upper limb motor recovery after stroke, technology-assisted rehabilitation, and life after stroke. Current projects include brain-computer interface training for patients, digital monitoring, and high intensity gait training. She also has a deep interest in clinical translation of research. Our conversation mainly centers on the use of technology in neuro-rehab and stroke recovery. We also discuss what the future of neuro-rehab may look like and what aspects of various tools and technology are most useful for patients and clinicians. Recorded: March 14, 2024. Host: Robert Murcko
Key Moments:
0:00 Introduction
1:38 Initial Interest in NeuroRehabilitation
3:20 What is NeuroRehabilitation?
6:22 Examples of Tech Applied to NeuroRehab
9:38 Spatial Neglect
12:01 Precision NeuroRehabilitation
17:23 Current State of Technology in NeuroRehab
19:50 Co-Design: Scaling Up Technology in NeuroRehab
24:00 BCI Research for Upper Limb Paresis After Stroke
28:15 Not There Yet with BCI: Future Directions
29:13 Regulators & Payment
30:40 Predictions for Applications of Technology to Clinical NeuroRehab
34:00 Focus on the End Users
34:50 Conclusion and Contact Info
Links:
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Brunner's LinkedIn: https://www.linkedin.com/in/iris-brunner-83b91b73/
Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe
Interview with Dr. Joern Rickert. He is the CEO of Neudio, a non-invasive neurotechnology company focused on brain wave modulation and generating music from brainwaves, with the goal of improving mental well-being through personalized music experiences. This episode covers a wide range of interesting topics, where Dr. Rickert and I discuss: his background in neurotechnology and entrepreneurship from Cortec, the challenges and advantages of non-invasive vs. invasive neurotechnologies, the differences in signal processing, Neudio's 'closed-loop' approach to brain activity modulation, comparisons with other neurotechnology companies like Neurable, and future outlook for the company and the broader neurotechnology field. Recorded: May 2024. Host: Neil Raman
Key Moments:
0:00 Introduction
0:57 Beginnings of Neudio + Transition from Cortec
3:18 Advantages of Non-Invasive Technologies
5:12 Drawbacks with Invasive Technology
8:48 Non-Invasive Advantages with Neudio
13:06 Evolution of Signal Processing and Effects in the Neurotech Field
15:30 Signal Processing with Neudio
17:44 Future Impacts with Neudio
19:48 Differentiating Neudio from Alternative Solutions/Companies
24:42 Next Steps with Neudio
Links:
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Joern Rickert LinkedIn: https://www.linkedin.com/in/joern-rickert-3386231a/
Neil Raman LinkedIn: https://www.linkedin.com/in/neil-raman21/
Neudio: https://www.neudio.com/
Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe
Kaustubh Deshpande is the Co-Founder of Eywa Neuro. He previously spent time as an engineer at Neuralink and NeuroNexus. In our conversation we discuss clinical translation, the neurotech startup space, running your own company, India’s neurotech ecosystem, the founding of Eywa Neuro, the future of Eywa Neuro, how to break into neurotech, and more! Recorded: January 15, 2024. Hosts: Robert Murcko and Yuqing Wang.
Key Moments:
0:00 Intro
8:13 Initial Interest in Neurotechnology
13:07 Clinical Translation Wisdom
16:39 Polyimide Trade Space
22:17 Building Your Own Company vs Working at a Startup
27:14 India’s Neurotech Ecosystem
32:07 Future of Eywa Neuro
34:47 Does neurotech need more experts from a certain domain?
38:58 How to break into neurotech
44:34 Future of Neurotech
50:27 Conclusion
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Kaustubh Deshpande LinkedIn: https://www.linkedin.com/in/kaustubh-deshpande-3931b8157/
Eywa Neuro: https://eywaneuro.com/
Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe
James Hamet has been working in AI and neurotech since his undergrad days. He is a serial neurotech founder and has been deeply involved with both Neurable and Vistim Labs. Our interview covers a range of topics: his early days in neurotech, lessons learned from his time at Neurable, an overview of Vistim’s products/tech, his vision for the future of the space (both short term and long term), the differences between going bootstrapped vs VC-funded, advice for founders, and more. Recorded: March 7, 2024. Host: Robert Murcko.
Key Moments:
0:00 Intro
3:45 Initial Involvement in Neuroscience/Neurotech
7:29 Founding of Vistim Labs
10:30 Learnings from Neurable Inform Current Work
13:25 Venture Funding Pros/Cons
19:00 Vistim Labs Tech/Product
22:47 Vistim Labs Involvement w/ Research & Academia
25:47 Researchers are kind of like investors
26:23 Vistim Labs Competitors
31:01 Vistim Labs Short-Term Future
33:23 The Secret of All Business
35:10 Vistim Labs Long-Term Vision
40:50 Advice for Breaking Into Neurotech
44:50 The Future of Neurotech
48:57 Conclusion
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
James Hamet LinkedIn: https://www.linkedin.com/in/jchamet/
Ridge Neurotech: https://ridgeneurotech.beehiiv.com/subscribe
Interview with Yacine Achiakh. He is the CEO and co-founder of Wisear, a company working on building the neural interface and human-machine interface platform technology of the future. Their goal is to enable people to have seamless, voiceless, and touchless control over their everyday devices. Their first application of this technology is earbuds outfitted with electrodes that can pick up biosignals (EEG, EMG, EOG, etc.) and convert them into control signals for various devices. This episode is jam-packed with interesting and useful information from start to finish.
Yacine and I talk for over an hour discussing a range of topics like: his career journey before founding Wisear, quitting his job to start the company, inspiration from Neuralink, scrappy early stage building & prototyping, development of Wisear’s technology stack, techniques to reduce electromagnetic noise, strategic decisions to get their product into more hands, the value of collecting data, hardware agnostic technology frameworks, possible research partnerships, neural interfaces & human-machine interfaces of the future, the changing form factors of our devices & interactions with technology, advice for students, advice for founders, the interconnected neurotech community, why its hard to bootstrap in neurotech, why its useful to raise a large first round of venture capital funding in neurotech, short term future of neurotechnology, long term future of neurotechnology, and neurotech’s upcoming eventual “GenAI moment.”
At the conclusion of the episode, Yacine gives a brief demonstration of Wisear’s technology and discusses opportunities to become part of Wisear’s alpha testing group, beta testing group, or the broader community that they are working to build. Recorded March 28, 2024. Host: Robert Murcko
Key Moments:
0:00 Introduction
3:00 Initial Interest in Neurotechnology/Neuroscience
4:04 Inspiration from Neuralink (SF Soccer Game)
7:55 Wisear’s Founding
8:49 Quitting Job and Scrappy Tinkering
10:24 Human-Machine Interface: Control
11:42 Early Prototype
12:47 Early Funding and Hiring a Small Team
13:54 Product and Technology Overview
20:32 Neural Interface Platform Tech: Form Agnostic (Earphones, Glasses, etc.)
21:47 A Community of Users
23:02 Wisear Silent Speech Controls
25:51 Use Cases of Wisear’s Existing Products and Technology
30:18 Wisear Applications in Augmented Reality
33:15 Neurotech CEO: Day-to-Day
38:02 Background in AI and Management at Criteo Informing Wisear
43:07 Wisear’s Competitors and the Vibrant Neurotech Community
46:37 Next Steps and Future Vision for Wisear
50:25 Advice for Breaking Into Neurotech
54:49 Advice for Neurotech Founders
58:13 Neurotechnology Predictions
1:00:52 Wisear Demo
1:03:38 Conclusion
Free Neurotechnology Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Wisear Website: https://www.wisear.io/
Yacine Achiakh’s LinkedIn: https://www.linkedin.com/in/yacineachiakh/
Robert Murcko’s LinkedIn: https://www.linkedin.com/in/robert-murcko/
Interview with VCU Bioengineering Research Scientist Dr. Geetanjali Bendale. Some of the topics we discuss include her current work in nerve repair and regeneration, her past work in bioelectronics/neurotechnology, translating basic science into the clinic, partnerships with surgeon scientists, the future of neurotech, and advice for students looking to get into this space. Recorded January 15, 2024. Host: Robert Murcko
Key Moments:
0:00 Introduction
6:38 Initial Interest in Neuroscience?
7:18 Dreams of Being a Surgeon
9:53 Amazed by the Details of Neurobiology
12:43 Neuromodulation w/ Miniature Wireless Stimulator for Small Peripheral Nerves
16:18 Direct Vagus Nerve to Spleen Communication Discovered
20:56 Nerve Tape: Sutureless Coaptation Device to Repair Peripheral Nerve Defects
29:43 Neuromuscular Repair - Current Research Focus and Future Directions
34:20 Autograft vs Allograft
37:05 Predictions for the Future of Neurotechnology
43:57 Tips for Students Looking to Build a Career in Neurotech
47:44 Conclusion and Contact Information
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Bendale’s LinkedIn: https://www.linkedin.com/in/geetanjali-bendale-1844a834/
Interview with Greg Alden. He is the CEO of Diagnostic Biochips – a company providing high fidelity research tools to neuroscientists for electrophysiology and more. He spent the early years of his career optimizing data communications to solve big problems in the domains of broadband and mobile communications. He now brings this set of useful expertise to the neurotech world. We have a conversation talking about everything from the future of neurotechnology innovation, Greg’s journey into the field (in part sparked by his diagnosis with a neurological condition), management principles for a technical organization, and more! Recorded January 16, 2024. Hosts: Robert Murcko and Yuqing Wang.
Key Moments
0:00 Intro
1:54 Parkinson’s Diagnosis
3:06 Applying Tech to Neuro Problems
4:08 Brain as a Distributed Computing Networking Function
5:03 Interest in Neuroscience
7:14 Involvement with Diagnostic Biochips
9:46 Commercialization of Diagnostic Biochips’ Products
11:30 Transitioning from Telecom to Neurotech
14:03 Market Landscape and Diagnostic Biochips’ Place In It
17:21 From Idea Stage through Go-to-Market
21:20 Advice for Academics Looking to Translate Their Technology
23:59 Technical vs. Business Priorities
26:29 Diagnostic Biochips’ Products and Offerings
29:28 Cloud-Based Analysis Platform
35:24 Diagnostic Biochips Contributions to the Field of Neuroscience
40:03 Advice for Getting Involved with Neurotech
42:23 The Future of Neurotechnology
46:42 Conclusion and Contact Information
Links
Free Neurotech Newsletter:
https://neurotechnologynews.beehiiv.com/subscribe
Diagnostic Biochips: https://diagnosticbiochips.com/
Greg’s LinkedIn: https://www.linkedin.com/in/gregjalden/
Interview with Dr. Matthew Wall. He is a neuroscientist, psychologist, and fMRI (brain imaging) specialist with Imperial College London and Invicro (a CRO focused on medical imaging). His research has explored the domains of neuropsychopharmacology, addiction, psychedelics, cannabis, sex hormones, pain, weight loss, and much more. We discuss Dr. Wall’s journey into the field, his recent projects, innovations in fMRI & medical imaging, how AI is going to change everything, and the future of neurotech. Recorded January 11, 2024. Host: Robert Murcko
Key Moments
0:00 Intro
3:56 What are you working on now? (Sex, Cannabis, Psychedelics, and more)
15:26 Scientific Theories Behind Psychedelic Applications in Mental Health
19:18 FDA and Psychedelics
20:36 Innovations in fMRI Imaging Over the Years
24:50 Contribution of AI to fMRI and Neuroimaging Innovation
26:53 Background on Data Streams an fMRI Scanner Provides
29:14 PETxfMRI & EEGxfMRI
32:25 fMRI Brain-Computer Interfaces
35:16 Related modalities: fNIRS, MEG
36:12 Minimizing fMRI and why its so large
37:49 Bedside fMRI
38:11 Predictions for the Future of Neurotech and fMRI
45:21 Conclusion and Contact Information
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Wall’s Link Tree: https://linktr.ee/mbwall
Interview with Michael Byrne, the CEO and Co-Founder of sleep-focused neurotech startup, Bia Neuroscience. We discuss the importance of sleep, Michael’s journey into the realm of sleep technology, Bia’s product and differentiation, finding technical co-founders, team building as a business focused executive, aligning business/technical strategies, the future of neurotech, advice for young people looking to break into the space, and more! Recorded March 20, 2024. Host: Robert Murcko
Key Moments
0:00 Intro
4:38 Initial Interest in Neuroscience and Neurotechnology
5:50 Interest in Sleep
7:45 Founding Story of Bia Neuroscience
9:57 Bia’s Product: Capabilities and Customer Fit
12:31 Audio Component of Bia’s Product
14:10 Bia Neuroscience’s Competitors and Market Landscape
15:51 Finding Technical and Scientific Co-Founders
17:44 Finding Technical Staff
20:24 Skills and Mindsets for Being an Operator in a Technical Space
23:05 Ego (Don’t Be Scared to Ask “Dumb Questions”)
24:10 Aligning Business Strategy with Technical Goals
28:20 Day-to-Day for a Neurotech Executive
31:11 Advice for Breaking into Neurotech
33:11 Advice for Neuroscience or Neurotech Co-Founders
35:32 Future of Neurotechnology
38:18 Content Recommendations
39:41 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Bia Neuroscience Website: https://getbia.com/
Michael Byrne’s LinkedIn: https://www.linkedin.com/in/michael-kp-byrne/
Michael Byrne’s E-Mail: michael@getbia.com
Interview with Caitlin Baltzer, the CEO and Co-Founder of neuroimaging and brain analytics startup, MYndspan. She shares some details about Magnetoencephalography (MEG), the modality her startup uses for neuroimaging. She also gives us the story behind MYndspan’s founding and how she ended up where she is today. You’ll see some clues about what’s next for MYndspan and a short conversation about the future of neurotech at large. Recorded March 18, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
4:50 Initial Interest in Neuroscience and Neurotechnology
6:43 MYndspan Founding and Timeline
10:20 Imaging and Report Generation Process (User Experience)
12:14 Idea for MYndspan: Eureka Moment or Slow Buildup
13:56 Brain Analytics
17:02 Magnetoencephalography (MEG) Explanation
20:18 MYndspan’s Key Product
23:31 Direct-to-Consumer (D2C) Framework
24:11 MYndspan’s Locations
25:08 CEO with Banking and Strategy Background
26:30 Topics Caitlin is Passionate About
27:32 Transition from COO to CEO
29:42 Day-to-Day for a CEO
31:02 A Rising Tide Lifts All Boats
32:36 MYndspan’s Differentiation and Competitors
34:40 What’s next for MYndspan
36:23 Advice: You Don’t Need a Perfect Plan
38:30 Future of Neurotechnology
41:49 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
MYndspan Website: https://myndspan.com/
